Location History:
- Cheongju-si, KR (2017)
- Chungcheongbuk-do, KR (2018 - 2021)
Company Filing History:
4 out of 22 
3 out of 321 
Years Active: 2017-2021
Title: Innovations by JongKoo Kang in Asthma and COPD Treatment
Introduction
JongKoo Kang is a notable inventor based in Chungcheongbuk-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). With a total of four patents to his name, his work focuses on innovative compositions that aim to improve patient outcomes.
Latest Patents
One of JongKoo Kang's latest patents is a composition containing a monoacetyldiacylglycerol compound as an active ingredient for preventing or treating asthma. This invention relates to a pharmaceutical composition that not only addresses asthma but also offers a functional health food composition for the same purpose. The monoacetyldiacylglycerol compound inhibits the expression of IL-4 in EL-4 cells, reduces airway hypersensitivity in asthma-induced animal models, and prevents the infiltration of inflammatory cells into the bronchial tubes. Furthermore, it effectively inhibits the generation of IgE in serum and bronchoalveolar lavage fluid, showcasing a superior therapeutic effect without toxicity.
Another significant patent by Kang involves a composition containing a monoacetyldiacylglycerol compound for preventing or treating chronic obstructive pulmonary disease. Similar to his asthma treatment, this invention provides a pharmaceutical composition and a functional health food composition aimed at COPD. The compound inhibits IL-4 expression in EL-4 cells and inflammatory cell infiltration in animal models. It also demonstrates an excellent effect in inhibiting the expression of CXCL-1, TNF-α, or MIP-2, thus overcoming the side effects of existing therapeutic agents for COPD.
Career Highlights
Throughout his career, JongKoo Kang has worked with prominent organizations such as Enzychem Lifesciences Corporation and the Korea Research Institute of Bioscience and Biotechnology. His experience in these institutions has allowed him to develop and refine his innovative ideas in the pharmaceutical field.
Collaborations
Some of his notable coworkers include Sei-Ryang Oh and Kyung Seop Ahn. Their collaborative efforts have contributed to the advancements in the research and development of respiratory disease treatments.
Conclusion
JongKoo Kang's innovative work in the field of respiratory disease treatment has the potential to significantly improve the quality of life for patients suffering from asthma and COPD. His contributions through his
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.